81 related articles for article (PubMed ID: 15332767)
1. Blood pressure control and target organ complications among hypertensive patients in southern Saudi Arabia.
Ahmed ME; El-Awad IB
East Mediterr Health J; 2001; 7(4-5):689-96. PubMed ID: 15332767
[TBL] [Abstract][Full Text] [Related]
2. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
4. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
5. Hypertension control in a community health centre at Riyadh, Saudi Arabia.
Siddiqui S; Ogbeide DO; Karim A; Al-Khalifa I
Saudi Med J; 2001 Jan; 22(1):49-52. PubMed ID: 11255611
[TBL] [Abstract][Full Text] [Related]
6. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
7. Influence of metabolic syndrome on hypertension-related target organ damage.
Mulè G; Nardi E; Cottone S; Cusimano P; Volpe V; Piazza G; Mongiovì R; Mezzatesta G; Andronico G; Cerasola G
J Intern Med; 2005 Jun; 257(6):503-13. PubMed ID: 15910554
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of hypertensive target organ damage in Africa: a review of published studies.
Mensah GA; Barkey NL; Cooper RS
J Hum Hypertens; 1994 Nov; 8(11):799-808. PubMed ID: 7853322
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
10. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
11. Patient satisfaction with antihypertensive therapy.
Chen K; Chiou CF; Plauschinat CA; Frech F; Harper A; Dubois R
J Hum Hypertens; 2005 Oct; 19(10):793-9. PubMed ID: 15951740
[TBL] [Abstract][Full Text] [Related]
12. [Epidemiology of arterial hypertension and organ damage].
Licata G
Ann Ital Med Int; 1994 Oct; 9 Suppl():44S-49S. PubMed ID: 7857756
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
[TBL] [Abstract][Full Text] [Related]
14. Predictors of adverse outcome among patients with hypertension and coronary artery disease.
Pepine CJ; Kowey PR; Kupfer S; Kolloch RE; Benetos A; Mancia G; Coca A; Cooper-DeHoff RM; Handberg E; Gaxiola E; Sleight P; Conti CR; Hewkin AC; Tavazzi L;
J Am Coll Cardiol; 2006 Feb; 47(3):547-51. PubMed ID: 16458134
[TBL] [Abstract][Full Text] [Related]
15. High blood pressure despite treatment: results from a cross-sectional primary healthcare-based study in southern Sweden.
Hedblad B; Nerbrand C; Ekesbo R; Johansson L; Midlöv P; Brunkstedt I; Svensson P; Gyllerup S; Sträng B; Persson R; Janzon L
Scand J Prim Health Care; 2006 Dec; 24(4):224-30. PubMed ID: 17118862
[TBL] [Abstract][Full Text] [Related]
16. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension.
White WB
Blood Press Monit; 2008 Apr; 13(2):123-9. PubMed ID: 18347448
[TBL] [Abstract][Full Text] [Related]
17. Diuretics for cardiovascular prevention in the elderly.
Hanon O; Seux ML; Lenoir H; Rigaud AS; Girerd X; Forette F
J Hum Hypertens; 2004 Dec; 18 Suppl 2():S15-22. PubMed ID: 15592568
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study.
Cuspidi C; Meani S; Valerio C; Fusi V; Catini E; Sala C; Magrini F; Zanchetti A
Blood Press; 2005; 14(1):25-31. PubMed ID: 15823944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
